Valuation : Alkem Laboratories Limited

Market Cap 634B 6.67B 5.76B 5.42B 4.94B 9.28B 9.34B 64.19B 24.92B 322B 25.06B 24.51B 1,069B P/E 2027 *
27.6x
P/E 2028 * 24x
Enterprise Value 621B 6.54B 5.64B 5.31B 4.84B 9.08B 9.15B 62.86B 24.41B 316B 24.54B 24.01B 1,047B EV / Sales 2027 *
3.72x
EV / Sales 2028 * 3.26x
Free-Float
37.56%
Yield 2027 *
0.93%
Yield 2028 * 1.04%
1 day-1.00%
1 week-0.99%
Current month-1.00%
1 month-7.87%
3 months-3.60%
6 months-6.01%
Current year-3.73%
1 week 5,270
Extreme 5270
5,400
1 month 5,173.5
Extreme 5173.5
5,771
Current year 5,085
Extreme 5085
5,933
1 year 5,085
Extreme 5085
5,933
3 years 3,440.05
Extreme 3440.05
6,440
5 years 2,835
Extreme 2835
6,440
10 years 1,400
Extreme 1400
6,440
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 2024-01-31
Director TitleAgeSince
Director/Board Member 44 2013-08-08
Director/Board Member 63 2008-02-10
Director/Board Member 45 2019-11-10
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%-0.99% - - 6.7B
+0.28%-6.97%+58.34%+109.31% 1,031B
+2.01%-0.68%+53.07%+67.73% 641B
+1.39%-1.71%+23.57%+76.91% 453B
-1.50%-6.18%+33.50%+33.50% 349B
+6.25%+3.31%+29.46%+46.64% 290B
-0.07%-1.22%+1.46%+12.19% 252B
+1.92%-1.29%+52.28%+70.91% 232B
+0.51%-1.79%-18.09%-53.86% 201B
+2.45%+2.17%+32.71%+96.03% 181B
Average +1.10%-2.98%+29.59%+51.04% 403.31B
Weighted average by Cap. +1.14%-3.97%+38.53%+66.75%

Financials

2027 *2028 *
Net sales 167B 1.76B 1.52B 1.43B 1.3B 2.44B 2.46B 16.92B 6.57B 84.9B 6.6B 6.46B 282B 186B 1.96B 1.69B 1.59B 1.45B 2.72B 2.74B 18.81B 7.3B 94.42B 7.34B 7.18B 313B
Net income 23.14B 244M 210M 198M 180M 339M 341M 2.34B 910M 11.77B 915M 895M 39.06B 27.15B 286M 247M 232M 212M 397M 400M 2.75B 1.07B 13.8B 1.07B 1.05B 45.83B
Net Debt -13.08B -138M -119M -112M -102M -191M -193M -1.32B -514M -6.65B -517M -506M -22.07B -28.06B -296M -255M -240M -219M -411M -414M -2.84B -1.1B -14.26B -1.11B -1.09B -47.35B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
26-09-01 ₹5,300.00 -1.00% 1,201
26-08-31 ₹5,353.40 +0.06% 958
26-08-28 ₹5,350.15 +0.67% 1,251
26-08-27 ₹5,314.35 -0.48% 1,924
26-08-26 ₹5,340.20 -0.13% 25,858
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,300.00INR
Average target price
5,948.55INR
Spread / Average Target
+12.24%

Quarterly revenue - Rate of surprise